Thalidomide for graft-versus-host disease after bone marrow transplantation. 1988

J H Saurat, and M Camenzind, and C Helg, and B Chapuis

UI MeSH Term Description Entries
D008297 Male Males
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

J H Saurat, and M Camenzind, and C Helg, and B Chapuis
January 1988, Lancet (London, England),
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
January 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
December 1988, The New England journal of medicine,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
November 1983, Canadian Medical Association journal,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
October 1995, Transplantation proceedings,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
March 1984, Lancet (London, England),
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
January 1986, Progress in clinical and biological research,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
March 2015, The Journal of dermatology,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
January 1989, Current opinion in immunology,
J H Saurat, and M Camenzind, and C Helg, and B Chapuis
January 1984, Journal of the Association of Pediatric Oncology Nurses,
Copied contents to your clipboard!